Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

53.0K
Overview
53.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Development of Immunocompetence01:22

Development of Immunocompetence

1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

4.2K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing the use of vaccine impact modeling for immunization decisions in low- and middle-income countries.

Vaccine·2026
Same author

Strengthening immunization and health systems to counter effects of climate change.

Vaccine·2026
Same author

Digital transformation and the Immunization agenda 2030.

Bulletin of the World Health Organization·2025
Same author

No compelling evidence that vaccination with streptococcus pyogenes group A carbohydrate elicits cross-reactive rheumatic fever autoantibodies.

NPJ vaccines·2025
Same author

Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines.

Nature communications·2025
Same author

Impact of RSV Prevention in Infancy on Prevalence of Asthma Among 9-14-Year-old Native American Children in the Southwest United States.

The Pediatric infectious disease journal·2025
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.7K

Prioritizing vaccines for developing world diseases.

Allan Saul1, Katherine L O'Brien2

  • 1GSK Vaccines Institute for Global Health, Siena, Italy.

Vaccine
|December 27, 2016
PubMed
Summary
This summary is machine-generated.

New vaccine development must prioritize diseases disproportionately affecting low- and middle-income countries. The SMART vaccine algorithm was assessed to guide this crucial global health initiative.

Keywords:
Developing worldNeglected diseasesPrioritizationStrategic Multi-Attribute Ranking ToolVaccines

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.7K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K

Related Experiment Videos

Last Updated: Mar 9, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.7K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.7K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K

Area of Science:

  • Global Health
  • Vaccinology
  • Infectious Disease Epidemiology

Background:

  • Significant global health disparities persist, particularly in low- and middle-income countries (LMICs) facing a high burden of infectious diseases.
  • While vaccines are effective, registered vaccines do not address 60% of the current infectious disease burden, especially in developing nations.
  • Limited resources necessitate strategic prioritization for new vaccine development.

Purpose of the Study:

  • To assess the Suitability, Manufacturability, Accessibility, Regulatory, and Training (SMART) vaccine algorithm for prioritizing vaccine development for diseases prevalent in developing countries.
  • To identify key criteria within the standard SMART set for LMIC-specific vaccine prioritization.
  • To explore potential additional criteria for enhancing vaccine prioritization in LMICs.

Main Methods:

  • A working group convened as part of the GLOBAL HEALTH 2035: Mission Grand Convergence meeting.
  • The group evaluated the existing SMART vaccine algorithm framework.
  • Discussion focused on the relevance and applicability of standard SMART criteria and the need for LMIC-specific considerations.

Main Results:

  • The SMART algorithm provides a structured approach to vaccine prioritization.
  • Certain standard SMART criteria were identified as particularly crucial for LMIC contexts.
  • The need for adapting or augmenting the SMART criteria to better suit the unique challenges and disease burdens in developing countries was highlighted.

Conclusions:

  • Prioritizing vaccine development for diseases impacting LMICs is essential for achieving global health equity.
  • The SMART vaccine algorithm offers a valuable framework but requires refinement for effective application in developing world contexts.
  • Further consideration of specific criteria is needed to optimize vaccine development strategies for the "Grand Convergence" by 2035.